-
Mashup Score: 0
On April 29, 2024, the Food and Drug Administration granted traditional approval to tisotumab vedotin-tftv (Tivdak, Seagen Inc. [now a part of Pfizer Inc.]) fo
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4OCE PULSE: May is the pause between annual meetings - 6 hour(s) ago
Click to share this newsletter with your colleagues! We enjoyed meeting many FDA-AACR Fellows at the AACR Annual Meeting in San Diego in early April. As we head into May and June, we will be looking forward to the ASCO Annual Meeting in Chicago. Check out our sessions! Read on for another interesting workshop on May 9 on trial designs, and browse the ICYMI section for events you missed—add them to your browser tabs now! We hope to see many of you at the 2024 ASCO Annual Meeting in Chicago, May 31-June 4
Source: content.govdelivery.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2
On Tuesday, December 12, 2023, CDER’s Office of Communication, Division of Drug Information (DDI) will host a webinar titled: FDA Drug Topics: An Overview of FDA’s Project Facilitate Oncology Expanded Access Program. Expanded access, sometimes called “compassionate use”, is a potential pathway for a
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 36Search for FDA Guidance Documents - 3 day(s) ago
Search for official FDA guidance documents and other regulatory guidance for all topics
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 9OCE Pediatric Oncology Program - 3 day(s) ago
Promoting the development of safe and effective new drugs and biologics to treat cancer in children
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 11Trading Places: Regulator as Patient, Patient as Regulator - 3 day(s) ago
This session at the AACR Annual Meeting 2024 explored how being a patient or caregiver has impacted how drugs and clinical trials are reviewed within the U.S. FDA.…
Source: vimeo.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4OCE Oncology News - 4 day(s) ago
A monthly newsletter for oncology/hematology fellows, junior faculty and scientists
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 66Project Asha - 5 day(s) ago
Collaboration to increase cancer clinical trial access in India
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Professional Education and Resources - 5 day(s) ago
Oncology Center of Excellence professional education projects and resources – 2023 OCE Annual Report
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 34
On April 23, 2024, the Food and Drug Administration granted accelerated approval to tovorafenib (Ojemda, Day One Biopharmaceuticals, Inc.) for patients 6 months
Source: www.fda.govCategories: General Medicine News, Onc News and JournalsTweet
FDA granted traditional approval to tisotumab vedotin-tftv for recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. Tisotumab vedotin-tftv previously received accelerated approval for this indication. https://t.co/plnR0xSPDq #OCENewsBurst